Maxigen Biotech Inc (MBI, 和康生技), which makes cosmetics and surgical materials, is set to shift to the main bourse from the Emerging Stock Market (興櫃市場) on Dec. 20.
The company has acquired 26 permits for its medical materials to be used for surgery in Taiwan, the US, Europe and Singapore over the past two years, which are expected to help boost its revenue starting next year, Maxigen president and CEO Edward Chang (張立言) said at an investors‘ conference yesterday.
“It took some time to persuade doctors and hospitals to use our products,” Chang said.
Maxigen signed a contract with a company listed in China to sell Formaderm — an antiwrinkle treatment — Chang said, adding that it is also considering taking over local companies to expand its retail network.
During the January-to-October period, Maxigen posted revenue of NT$190.26 million (US$6.42 million). The figure represents a 0.87 percent drop from the NT$191.26 million recorded a year ago, a company filing with the Taiwan Stock Exchange showed.
Cosmetics product sales accounted for about 46 percent of Maxigen’s revenue, while surgical material sales accounted for 53 percent, the company said.
The business started to turn a profit last year, Chang said, adding that he expects profits will see an annual increase next year.
From January to September, the company posted a profit of NT$753,000, down from NT$4.99 million a year ago, the filing said.
Chang said the decline was mostly caused by decreasing non-operating profits resulting from the end of government subsidies.
Maxigen started construction on a new factory in Taoyuan County in August that is slated to be completed by the first half of 2015, Chang said, adding that the plant is to increase capacity by three to six-fold.
The company plans to issue about 7,000,000 shares priced at between NT$32 and NT$35, and is to use the proceeds to set up retail routes in China and apply for permits for its surgical products.
US-based medical device firm NuVasive Inc owns a 7 percent stake in Maxigen and is responsible for selling FormaGraft, a bone substitute, in the US and Europe, the Taiwanese company said.
Meanwhile, drugmaker TWi Pharmaceuticals Inc (安成藥) saw its shares rise 33.06 percent to NT$330 from the NT$248 target it set for its debut on the GRETAI Securities Market yesterday.
TWi Pharmaceuticals plans to launch its first products in the US starting next year. It said it expects to swing to the black starting in 2015, after six to eight of its products enter the US market.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said its materials management head, Vanessa Lee (李文如), had tendered her resignation for personal reasons. The personnel adjustment takes effect tomorrow, TSMC said in a statement. The latest development came one month after Lee reportedly took leave from the middle of last month. Cliff Hou (侯永清), senior vice president and deputy cochief operating officer, is to concurrently take on the role of head of the materials management division, which has been under his supervision, TSMC said. Lee, who joined TSMC in 2022, was appointed senior director of materials management and
Nvidia Corp CEO Jensen Huang (黃仁勳) on Thursday met with US President Donald Trump at the White House, days before a planned trip to China by the head of the world’s most valuable chipmaker, people familiar with the matter said. Details of what the two men discussed were not immediately available, and the people familiar with the meeting declined to elaborate on the agenda. Spokespeople for the White House had no immediate comment. Nvidia declined to comment. Nvidia’s CEO has been vocal about the need for US companies to access the world’s largest semiconductor market and is a frequent visitor to China.
Hypermarket chain Carrefour Taiwan and upscale supermarket chain Mia C’bon on Saturday announced the suspension of their partnership with Jkopay Co (街口支付), one of Taiwan’s largest digital payment providers, amid a lawsuit involving its parent company. Carrefour and Mia C’bon said they would notify customers once Jkopay services are reinstated. The two retailers joined an array of other firms in suspending their partnerships with Jkopay. On Friday night, popular beverage chain TP Tea (茶湯會) also suspended its use of the platform, urging customers to opt for alternative payment methods. Another drinks brand, Guiji (龜記), on Friday said that it is up to individual
READY TO BUY: Shortly after Nvidia announced the approval, Chinese firms scrambled to order the H20 GPUs, which the company must send to the US government for approval Nvidia Corp chief executive officer Jensen Huang (黃仁勳) late on Monday said the technology giant has won approval from US President Donald Trump’s administration to sell its advanced H20 graphics processing units (GPUs) used to develop artificial intelligence (AI) to China. The news came in a company blog post late on Monday and Huang also spoke about the coup on China’s state-run China Global Television Network in remarks shown on X. “The US government has assured Nvidia that licenses will be granted, and Nvidia hopes to start deliveries soon,” the post said. “Today, I’m announcing that the US government has approved for us
RSS